Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

68 trials

NCT05517980
Recruiting
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
Phase 2 · China · 1 site
Registry update: 3 Nov 2026
NCT07305116
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · China · 1 site
Registry update: 3 Feb 2026
NCT06994845
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Phase 3 · Argentina, Australia, China, Hong Kong, Israel, Japan, Saudi Arabia, United States · 20 sites
Registry update: 9 Sept 2026
NCT07010250
Recruiting
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
Not applicable · France · 1 site
Registry update: 30 Jun 2026
NCT07585981
Recruiting
Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Not applicable · China · 1 site
Registry update: 14 May 2026
2024-518759-45-00
Recruiting
Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy.
Phase 3 · Poland · 8 sites
Registry update: 13 Mar 2026
NCT07030894
Recruiting
Nefecon and Ambrisentan in IgA Nephropathy
Phase 4 · China · 1 site
Registry update: 15 Sept 2025
NCT06989359
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 2 · Australia, Spain, United Kingdom, Hong Kong, Italy, South Korea, Taiwan, United States · 32 sites
Registry update: 20 Oct 2026
NCT07616700
Recruiting
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
Phase 2 · China · 1 site
Registry update: 1 Jun 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT07054684
Recruiting
Study of BHV-1400 in IgA Nephropathy
Phase 1 · United Kingdom, United States · 15 sites
Registry update: 23 Jun 2026
NCT06858319
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Phase 3 · Argentina, Australia, Canada, Spain, South Korea, Mexico, Malaysia, Taiwan, United States · 25 sites
Registry update: 17 Aug 2026
NCT07203404
Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
Early phase 1 · China · 1 site
Registry update: 3 Aug 2026
NCT06963827
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Argentina, Austria, Australia, Canada, Switzerland, China, Czechia, Germany, Spain, France, United Kingdom, Hong Kong, Hungary, Italy, Japan, South Korea, Malaysia, Netherlands, Norway, Poland, Sweden, Singapore, Slovenia, Taiwan, United States · 187 sites
Registry update: 4 Nov 2026
NCT06983028
Recruiting
Atacicept in Multiple Glomerular Diseases
Phase 2 · United States · 1 site
Registry update: 26 Jun 2026
NCT06350630
Recruiting
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
Phase 2 · France · 18 sites
Registry update: 9 Oct 2026
NCT07295808
Recruiting
Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)
Not applicable · France · 1 site
Registry update: 22 Dec 2025
NCT06926244
Recruiting
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
Not applicable · France · 1 site
Registry update: 23 Jun 2026
NCT07024563
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Phase 3 · China, Spain, Italy, Japan, South Korea, Taiwan, United States · 15 sites
Registry update: 30 Jul 2026
NCT06676579
Recruiting
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
Phase 2 · United States · 2 sites
Registry update: 9 Oct 2026
NCT07014826
Recruiting
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Phase 3 · China · 1 site
Registry update: 5 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.